BPIPO and DCB Partner with LINK-J for the First Regenerative Medicine Investment Event in Tokyo
TOKYO, April 29, 2025 /PRNewswire/ -- The inaugural Taiwan-Japan Investment and Industry Networking Event
{fullname}
About author
You should write because you love the shape of stories and sentences and the creation of different words on a page.
View all posts
Related posts
---
Amaran Biotech's Vaccine Adjuvant AB-801 Receives FDA Drug Master File (DMF) Filing Acknowledgement
HSINCHU, Dec. 2, 2025 /PRNewswire/ -- Amaran Biotech, a next-generation Contract Development and
---
Locus Cell, Taiwan-Based Cell and Gene Therapy CDMO, Signs MoU with Charles River at APAC Biomanufacturing Leadership Summit
SINGAPORE, March 12, 2026 /PRNewswire/ -- Locus Cell Co., Ltd. ("Locus Cell"), a Taiwan-based cell
---
Agri-Food Tech Startups Led by Taiwan's HAOSHi Attend SusHi Tech Tokyo 2026 to Build Industry and Investment Connections
TAIPEI and TOKYO, April 28, 2026 /PRNewswire/ -- A delegation of three food-tech startups led by Taiwan-based
---
Empowering Regenerative Medicine: 3A-GTP Technology Ushers in a New Epoch
Pioneering Green Energy Solutions: DrSignal Biotech and J" alt="Empowering Regenerative Medicine:
---
Porton Pharma Solutions and Aojin Life Sciences Announce Strategic Collaboration to Advance XDC Conjugate Drugs for Dual IND Filings in China and the U.S.
CHONGQING, China, Dec. 12, 2024 /PRNewswire/ -- Recently, Porton Pharma Solutions Ltd. ("Porton")
